InflaRx (IFRX) Accumulated Expenses (2022 - 2025)

InflaRx (IFRX) has disclosed Accumulated Expenses for 4 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Accumulated Expenses fell 38.57% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Dec 2025, down 38.57% year-over-year, with the annual reading at $1.4 million for FY2025, 38.57% down from the prior year.
  • Accumulated Expenses hit $1.4 million in Q4 2025 for InflaRx, down from $2.2 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.2 million in Q4 2024 to a low of $1.3 million in Q4 2022.
  • Historically, Accumulated Expenses has averaged $1.7 million across 4 years, with a median of $1.5 million in 2023.
  • Biggest five-year swings in Accumulated Expenses: grew 29.37% in 2023 and later crashed 38.57% in 2025.
  • Year by year, Accumulated Expenses stood at $1.3 million in 2022, then increased by 29.37% to $1.7 million in 2023, then increased by 27.38% to $2.2 million in 2024, then plummeted by 38.57% to $1.4 million in 2025.
  • Business Quant data shows Accumulated Expenses for IFRX at $1.4 million in Q4 2025, $2.2 million in Q4 2024, and $1.7 million in Q4 2023.